本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ikena Oncology, Inc.

1.43
0.0000
成交量:- -
成交额:- -
市值:6,900.97万
市盈率:- -
高:1.43
开:1.43
低:1.43
收:1.43
52周最高:18.00
52周最低:1.43
股本:4,825.85万
流通股本:3,328.22万
量比:0.67
换手率:- -
股息:- -
股息率:- -
每股收益(LYR):-1.0202
净资产收益率:-23.76%
总资产收益率:-18.32%
市净率:0.60
市盈率(LYR):-1.40

数据加载中...

2022/03/17

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/17

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/24

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/01/28

重要事件披露

8-K - Current report
2022/01/26

重要事件披露

8-K - Current report
2021/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/10

重要事件披露

8-K - Current report
2021/08/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/12

重要事件披露

8-K - Current report
2021/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/04/15

重要事件披露

8-K - Current report
2021/04/15

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals